Ramipril - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic drug sources for ramipril and what is the scope of patent protection?

Ramipril is the generic ingredient in two branded drugs marketed by King Pharms Llc, Accord Hlthcare, Actavis Elizabeth, Apotex, Aurobindo Pharma Ltd, Chartwell Molecular, Chartwell Rx, Cipla, Dr Reddys Labs Ltd, Hikma, Lupin, Ranbaxy Labs Ltd, Teva Pharms, Watson Labs, Zydus Pharms Usa, King Pfizer, Mylan Pharms Inc, and Zydus Pharms Usa Inc, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for ramipril. Twenty-one suppliers are listed for this compound.

Summary for ramipril

US Patents:	0
Tradenames:	2
Applicants:	18
NDAs:	19
Drug Master File Entries:	19
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	90
Clinical Trials:	167
Patent Applications:	7,285
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for ramipril
Drug Sales Revenues:	Drug sales revenues for ramipril
What excipients (inactive ingredients) are in ramipril?	ramipril excipients list
DailyMed Link:	ramipril at DailyMed

See drug prices for ramipril

See drug sales revenues for ramipril

Recent Clinical Trials for ramipril

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
John Paul II Hospital, Krakow	Phase 3
Pharmtechnology LLC	Phase 1
Ligand Research, LLC	Phase 1

See all ramipril clinical trials

Pharmacology for ramipril

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Medical Subject Heading (MeSH) Categories for ramipril

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents

US Patents and Regulatory Information for ramipril

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-001	Feb 27, 2007		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Chartwell Rx	RAMIPRIL	ramipril	CAPSULE;ORAL	077514-004	Jun 18, 2008		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa	RAMIPRIL	ramipril	CAPSULE;ORAL	078832-002	Sep 2, 2008	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Accord Hlthcare	RAMIPRIL	ramipril	CAPSULE;ORAL	202392-001	Apr 15, 2014	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ramipril

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pharms Llc	ALTACE	ramipril	CAPSULE;ORAL	019901-003	Jan 28, 1991	See Plans and Pricing	See Plans and Pricing
King Pharms Llc	ALTACE	ramipril	CAPSULE;ORAL	019901-002	Jan 28, 1991	See Plans and Pricing	See Plans and Pricing
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-004	Feb 27, 2007	See Plans and Pricing	See Plans and Pricing
King Pharms Llc	ALTACE	ramipril	CAPSULE;ORAL	019901-002	Jan 28, 1991	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.